MENU
+Compare
HQL
ETF ticker: NYSE
AS OF
Dec 24 closing price
Price
$17.29
Change
+$0.04 (+0.23%)
Net Assets
579.11M

HQL stock forecast, quote, news & analysis

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company... Show more

HQL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for HQL with price predictions
Dec 24, 2025

HQL in -0.83% downward trend, sliding for three consecutive days on December 18, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HQL declined for three days, in of 275 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for HQL turned negative on December 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 23, 2025. You may want to consider a long position or call options on HQL as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

HQL moved above its 50-day moving average on December 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HQL advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .

HQL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Industry description

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund’s Investment Adviser to have the potential for above-average growth.

Volume

The average weekly volume growth across all stocks in the abrdn Life Sciences Investors ETF was -74%. For the same stocks of the ETF, the average monthly volume growth was -83% and the average quarterly volume growth was -81%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 48
Price Growth Rating: 36
SMR Rating: 47
Profit Risk Rating: 57
Seasonality Score: 22 (-100 ... +100)
View a ticker or compare two or three
HQL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Fundamentals
Details
Category
Health
Address
2 Liberty Square9th FloorBoston
Phone
N/A
Web
https://www.teklacap.com/funds/hql/fund/fund-information/